Search Result

Isoforms Recommended:	PI3Kδ

Results for "

PI3K-δ

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Akt (16) Apoptosis (38) ATM/ATR (1) Autophagy (12) Bacterial (2) Bcl-2 Family (1) Bcr-Abl (1) Biochemical Assay Reagents (1) Btk (1) c-Fms (1) c-Myc (1) Casein Kinase (8) Caspase (2) CD3 (1) CDK (2) Checkpoint Kinase (Chk) (1) Cytochrome P450 (1) DNA-PK (5) Drug Intermediate (1) E3 Ligase Ligand-Linker Conjugates (1) EGFR (1) Epigenetic Reader Domain (3) ERK (1) G Protein-coupled Receptor Kinase (GRK) (1) HDAC (6) HIF/HIF Prolyl-Hydroxylase (1) Histone Methyltransferase (2) IFNAR (1) Interleukin Related (2) Isotope-Labeled Compounds (3) Kinesin (1) Lipase (1) MEK (4) Microtubule/Tubulin (1) Mitochondrial Metabolism (1) Mitophagy (7) MMP (1) mTOR (19) NF-κB (1) P-glycoprotein (1) p38 MAPK (1) Paraptosis (1) Parasite (2) PARP (1) PD-1/PD-L1 (1) PDK-1 (1) PERK (2) PI3K (186) PI4K (2) PPAR (1) PROTACs (3) Reactive Oxygen Species (ROS) (8) Reference Standards (17) SARS-CoV (2) VEGFR (1)
By Research Areas:	Cancer (149) Cardiovascular Disease (3) Infection (9) Inflammation/Immunology (46) Metabolic Disease (4) Neurological Disease (4)

By Targets:

Akt (16)

Apoptosis (38)

ATM/ATR (1)

Autophagy (12)

Bacterial (2)

Bcl-2 Family (1)

Bcr-Abl (1)

Biochemical Assay Reagents (1)

Btk (1)

c-Fms (1)

c-Myc (1)

Casein Kinase (8)

Caspase (2)

CD3 (1)

CDK (2)

Checkpoint Kinase (Chk) (1)

Cytochrome P450 (1)

DNA-PK (5)

Drug Intermediate (1)

E3 Ligase Ligand-Linker Conjugates (1)

EGFR (1)

Epigenetic Reader Domain (3)

ERK (1)

G Protein-coupled Receptor Kinase (GRK) (1)

HDAC (6)

HIF/HIF Prolyl-Hydroxylase (1)

Histone Methyltransferase (2)

IFNAR (1)

Interleukin Related (2)

Isotope-Labeled Compounds (3)

Kinesin (1)

Lipase (1)

MEK (4)

Microtubule/Tubulin (1)

Mitochondrial Metabolism (1)

Mitophagy (7)

MMP (1)

mTOR (19)

NF-κB (1)

P-glycoprotein (1)

p38 MAPK (1)

Paraptosis (1)

Parasite (2)

PARP (1)

PD-1/PD-L1 (1)

PDK-1 (1)

PERK (2)

PI3K (186)

PI4K (2)

PPAR (1)

PROTACs (3)

Reactive Oxygen Species (ROS) (8)

Reference Standards (17)

SARS-CoV (2)

VEGFR (1)

By Research Areas:

Cancer (149)

Cardiovascular Disease (3)

Infection (9)

Inflammation/Immunology (46)

Metabolic Disease (4)

Neurological Disease (4)

188

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Natural
Products

Isotope-Labeled Compounds

Antibodies

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-18085

Quercetin 195+ Cited Publications	Reactive Oxygen Species (ROS) PI3K Autophagy Mitophagy Apoptosis	Cancer
Quercetin, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a *PI3K* inhibitor with IC₅₀ of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-18085A

Quercetin hydrate 195+ Cited Publications	PI3K Autophagy Mitophagy Apoptosis Reactive Oxygen Species (ROS)	Cancer
Quercetin hydrate, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a *PI3K* inhibitor with IC₅₀ of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-102031

Linperlisib 1 Publications Verification YY-20394	PI3K	Inflammation/Immunology Cancer
Linperlisib (YY-20394) is a potent, orally bioavailable and selective inhibitor of *PI3Kδ* extracted from patent WO 2015055071 A1, compound 10; has an IC₅₀ of 6.4 nM .

HY-19962

Paxalisib 5 Publications Verification GDC-0084	PI3K mTOR	Cancer
Paxalisib (GDC-0084) is a brain penetrant inhibitor of *PI3K* and mTOR, with K_is of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively .

HY-13898

Taselisib 20+ Cited Publications GDC-0032; RG-7604	PI3K	Cancer
Taselisib (GDC-0032) is a potent *PI3K* inhibitor targets PIK3CA mutations, with K_is of 0.12 nM, 0.29 nM, 0.97 nM, and 9.1 nM for PI3Kδ, PI3Kα, PI3Kγ and PI3Kβ, respectively.

HY-17635

Leniolisib 1 Publications Verification CDZ173	PI3K	Inflammation/Immunology
Leniolisib (CDZ173) is a potent and selective *PI3Kδ* inhibitor. Leniolisib has the potential for immunodeficiency disorders treatment.

HY-N0146

Quercetin dihydrate 190+ Cited Publications	PI3K Apoptosis	Inflammation/Immunology Cancer
Quercetin dihydrate, a natural flavonoid, is a stimulator of recombinant SIRT1 and a *PI3K* inhibitor with *IC₅₀s of 2.4 μM, 3.0 μM and 5.4 μM for PI3K* γ, PI3K δ and PI3K β, respectively .**

HY-109068

Parsaclisib 2 Publications Verification INCB050465; IBI-376	PI3K	Cancer
Parsaclisib (INCB050465) is a potent, selective and orally active inhibitor of *PI3Kδ, with an IC₅₀* of 1 nM at 1 mM ATP. Parsaclisib shows approximately 20000-fold selectivity over other PI3K class I isoforms. Parsaclisib can be used for the research of relapsed or refractory B-cell malignancies ^[3].

HY-12644

Acalisib 1 Publications Verification GS-9820; CAL-120	PI3K	Cancer
Acalisib is a potent and selective *PI3Kδ* inhibitor with an IC₅₀ of 12.7 nM.

HY-12948

AMG319 1 Publications Verification	PI3K	Cancer
AMG319 is a potent and selective *PI3Kδ* kinase inhibitor with IC₅₀ of 18 nM.

HY-10111

TG100-115 2 Publications Verification	PI3K	Cardiovascular Disease Cancer
TG100-115 is a selective PI3Kγ/PI3Kδ inhibitor with IC₅₀s of 83 and 235 nM, respectively.

HY-50847

ZSTK474 15+ Cited Publications	PI3K Autophagy	Cancer
ZSTK474 is an ATP-competitive pan-class I *PI3K* inhibitor with IC₅₀s of 16 nM, 44 nM, 4.6 nM and 49 nM for PΙ3Κα, PI3Kβ, PI3Kδ and PI3Kγ, respectively.

HY-135827

Roginolisib 1 Publications Verification MSC2360844; IOA-244	PI3K	Inflammation/Immunology Cancer
Roginolisib (MSC2360844; IOA-244) is a potent, orally active and selective *PI3Kδ* inhibitor, with an IC₅₀ of 145 nM. Roginolisib shows highly selective against a panel of 278 additional kinases .

HY-109198

Zandelisib ME-401; PWT-143	PI3K Akt	Cancer
Zandelisib (ME-401) is a selective, orally active, non-covalent inhibitor of *PI3Kδ. Zandelisib can sustainably inhibit AKT* phosphorylation and downstream signaling pathways. Zandelisib can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma .

HY-16526

Pilaralisib 5 Publications Verification XL-147; SAR245408	PI3K	Cancer
Pilaralisib (XL147; SAR245408) is a potent and highly selective class I *PI3Ks inhibitor with IC₅₀s of 39 nM, 383 nM, 23 nM and 36 nM for PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ*.

HY-11080

PKI-179 1 Publications Verification	PI3K mTOR	Cancer
PKI-179 is a potent and orally active dual *PI3K/mTOR* inhibitor, with IC₅₀s of 8 nM, 24 nM, 74 nM, 77 nM, and 0.42 nM for *PI3K-α, PI3K-β, PI3K-γ, PI3K-δ* and mTOR, respectively. PKI-179 also exhibits activity over E545K and H1047R, with IC₅₀s of 14 nM and 11 nM, respectively. PKI-179 shows anti-tumor activity in vivo .

HY-10110

IC-87114 3 Publications Verification	PI3K	Cancer
IC-87114 is a potent and selective *PI3Kδ* inhibitor with IC₅₀ of 0.5 μM.

HY-19535A

Nemiralisib GSK2269557 free base	PI3K	Cancer
Nemiralisib (GSK2269557 free base) is a potent and highly selective *PI3Kδ* inhibitor with a pK_i of 9.9.

HY-17645

Tenalisib 1 Publications Verification RP6530	PI3K	Cancer
Tenalisib (RP6530) is a novel, potent, and selective *PI3Kδ* and PI3Kγ inhibitor with IC₅₀ values of 25 and 33 nM, respectively.

HY-16754

Seletalisib 2 Publications Verification UCB5857	PI3K	Inflammation/Immunology
Seletalisib (UCB5857) is potent and selective *PI3Kδ* inhibitor with an IC₅₀ of 12 nM.

HY-12869

AZD-8835 1 Publications Verification	PI3K	Cancer
AZD8835 is a potent and selective inhibitor of PI3Kα and *PI3Kδ* with IC₅₀s of 6.2 and 5.7 nM, respectively.

HY-13333

NVP-BAG956 BAG 956	PI3K	Cancer
NVP-BAG956 is an ATP-competitive *PI3K* inhibitor with IC50s of 34, 56, 112 and 444 nM for PI3Kδ, PI3Kα, PI3Kγ and PI3Kβ, respectively.

HY-19798

PI4KIIIbeta-IN-9 5 Publications Verification	PI4K PI3K	Cancer
PI4KIIIbeta-IN-9 is a potent PI4KIIIβ inhibitor with an IC₅₀ of 7 nM. PI4KIIIbeta-IN-9 also inhibits *PI3Kδ* and PI3Kγ with IC₅₀s of 152 nM and 1046 nM, respectively.

HY-17635A

Leniolisib phosphate 1 Publications Verification CDZ173 phosphate	PI3K	Inflammation/Immunology
Leniolisib (CDZ173) phosphate is a potent and selective *PI3Kδ* inhibitor. Leniolisib phosphate has the potential for immunodeficiency disorders treatment.

HY-12340

ETP-46321	PI3K	Cancer
ETP-46321 is a potent and orally bioavailable PI3Kα and *PI3Kδ* inhibitor with K_iapps of 2.3 and 14.2 nM, respectively.

HY-13514

TG 100713 2 Publications Verification	PI3K	Cancer
TG 100713 is an inhibitor of *PI3K, with IC₅₀s of 24, 50, 165, and 215 nM for PI3Kδ*, γ, α and β isoforms respectively .

HY-115870

AZD8154	PI3K	Inflammation/Immunology
AZD8154 is a selective PI3Kγδ dual inhibitor. AZD8154 can suppress PI3Kγ and PI3Kδ signaling pathway activation. AZD8154 can be used for the researches of inflammation and immunology, such as asthma .

HY-15280

GSK2292767	PI3K	Inflammation/Immunology
GSK2292767 is a potent and selective inhibitor of *PI3Kδ, with a pIC₅₀* of 10.1. GSK2292767 showing greater than 500-fold selective over the other PI3K isoforms. GSK2292767 can be used for the research of respiratory disease .

HY-112443

AZD3458	PI3K	Metabolic Disease Inflammation/Immunology Cancer
AZD3458 is a potent and remarkably selective PI3Kγ inhibitor with pIC₅₀s of 9.1, 5.1, <4.5, and 6.5 for PI3Kγ, PI3Kα, PI3Kβ, and *PI3Kδ*, respectively .

HY-176239

*PROTAC PI3Kδ* degrader-1**	PROTACs PI3K Akt Apoptosis Autophagy	Cancer
PROTAC PI3Kδ degrader-1 is a Lysine-targeted covalent *PI3Kδ* PROTAC degrader with a DC₅₀ of 3.98 nM. PROTAC PI3Kδ degrader-1 has a potent antiproliferative activity and selective PI3Kδ inhibition (IC₅₀: 8 nM). PROTAC PI3Kδ degrader-1 also significantly degrades p-AKT, induces cell cycle arrest in G1 phase and prompts cell apoptosis and autophagy. PROTAC PI3Kδ degrader-1 effectively inhibits the tumor growth in SU-DHL-6 xenograft mice model . Pink: PI3Kδ ligand (HY-169983); Blue: VHL ligase ligand (HY-112078); Black: linker (HY-W013381)

HY-101921

PI3Kδ-IN-1	PI3K	Inflammation/Immunology
PI3Kδ-IN-1 is a potent, selective, and efficacious *PI3Kδ* inhibitor with an IC₅₀ of 1.7 nM.

HY-147419

Vulolisib	PI3K	Cancer
Vulolisib is a potent and orally active phosphatidylinositol 3-kinase (PI3K) inhibitor, with IC₅₀ values of 0.2 nM, 168 nM, 90 nM and 49 nM for PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ, respectively. Antiproliferative and antineoplastic activity .

HY-150638

PI3Kδ/γ-IN-3	PI3K Apoptosis	Cancer
PI3Kδ/γ-IN-3 (Compound 58) is a potent and orally active *PI3Kδ* and PI3Kγ dual inhibitor with IC₅₀s of 1 nM and 16 nM, respectively. PI3Kδ/γ-IN-3 induces tumor cell apoptosis and can be used for B-cell malignancies research .

HY-W040417

Boc-L-cyclobutylglycine	PI3K	Others
Boc-L-cyclobutylglycine is a Boc-protected L-cyclic amino acid and synthetic intermediate in the preparation of purinyl quinazolinone *PI3Kδ* inhibitors .

HY-17635S

Leniolisib-d5 CDZ173-d₅	Isotope-Labeled Compounds PI3K	Inflammation/Immunology
Leniolisib-d5 is a deuterated labeled Leniolisib . Leniolisib (CDZ173) is a potent and selective *PI3Kδ* inhibitor. Leniolisib has the potential for immunodeficiency disorders treatment.

HY-11080A

PKI-179 hydrochloride 1 Publications Verification	PI3K mTOR	Cancer
PKI-179 hydrochloride is a potent and orally active dual *PI3K/mTOR* inhibitor, with IC₅₀s of 8 nM, 24 nM, 74 nM, 77 nM, and 0.42 nM for *PI3K-α, PI3K-β, PI3K-γ, PI3K-δ* and mTOR, respectively. PKI-179 hydrochloride also exhibits activity over E545K and H1047R, with IC₅₀s of 14 nM and 11 nM, respectively. PKI-179 hydrochloride shows anti-tumor activity in vivo .

HY-15288

PI3kδ inhibitor 1	PI3K	Cancer
PI3kδ inhibitor 1 is a potent and selective *PI3Kδ* inhibitor with an IC₅₀ of 3.8 nM.

HY-16122

CAL-130 Racemate	PI3K	Cancer
CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a *PI3Kδ* inhibitor.

HY-16122A

CAL-130	PI3K	Cancer
CAL-130 is a *PI3Kδ* and PI3Kγ inhibitor with IC₅₀s of 1.3 and 6.1 nM, respectively.

HY-112439

PI3Kdelta inhibitor 1	PI3K	Inflammation/Immunology Cancer
PI3Kdelta inhibitor 1 (Compound 5d) is a potent, selective and orally available *PI3Kδ* inhibitor with an IC₅₀ of 1.3 nM .

HY-122593

PI3Kδ-IN-5	PI3K	Cancer
PI3Kδ-IN-5 (compound 7n) is a highly potent and selective inhibitor of *PI3Kδ* with an IC₅₀ of 0.9 nM .

HY-40029

(S)-1-Boc-3-aminopiperidine (S)-(+)-3-Amino-1-boc-PIperidine	Biochemical Assay Reagents Drug Intermediate Checkpoint Kinase (Chk) PI3K	Others
(S)-1-Boc-3-aminopiperidine is a key intermediate for the synthesis of various novel inhibitors, such as CHK1 inhibitors and *PI3Kδ* inhibitors .

HY-109029

Dezapelisib INCB040093	PI3K	Cancer
Dezapelisib (NCB040093) is a potent inhibitor of phosphatidylinositol 3-kinase δ (PI3Kδ). Dezapelisib is a promising research strategy for select R/R B-cell lymphomas .

HY-12338

ON 146040	PI3K Bcr-Abl	Cancer
ON 146040 is a potent PI3Kα and *PI3Kδ* (IC₅₀≈14 and 20 nM, respectively) inhibitor. ON 146040 also inhibits Abl1 (IC₅₀<150 nM).

HY-125376

PI3Kδ-IN-3	PI3K	Cancer
PI3Kδ-IN-3 (Compound 11) is a **PI3Kδ inhibitor (IC₅₀*: 9 nM). PI3Kδ-IN-3 inhibits B cell function. PI3Kδ-IN-3 has good pharmacokinetic properties .***

HY-109068A

Parsaclisib hydrochloride 2 Publications Verification INCB050465 hydrochloride; IBI-376 hydrochloride	PI3K	Cancer
Parsaclisib hydrochloride (INCB050465 hydrochloride) is a potent, selective and orally active inhibitor of *PI3Kδ, with an IC₅₀* of 1 nM at 1 mM ATP. Parsaclisib hydrochloride shows approximately 20000-fold selectivity over other PI3K class I isoforms. Parsaclisib hydrochloride can be used for the research of relapsed or refractory B-cell malignancies ^[3].

HY-174396

PI3Kδ/HDAC6-IN-1	PI3K HDAC Bcl-2 Family Caspase Reactive Oxygen Species (ROS) Apoptosis Histone Methyltransferase Microtubule/Tubulin	Cancer
PI3Kδ/HDAC6-IN-1 (Compound 22E) is an orally active and dual inhibitor of *PI3Kδ* and HDAC6 with IC₅₀ values of 2.4 nM and 6.2 nM, respectively. PI3Kδ/HDAC6-IN-1 exhibits potent antiproliferative effects on non-Hodgkin lymphoma (NHL) cells and possesses in vivo antitumor activity without significant toxicity. PI3Kδ/HDAC6-IN-1 arrests the cell cycle at the G0/G1 phase and induces apoptosis. PI3Kδ/HDAC6-IN-1 blocks the PI3K/AKT/mTOR signaling pathway and increases the acetylation levels of α-tubulin and histone H3 .

HY-175369

PI3Kδ-IN-25	PI3K Akt PD-1/PD-L1 Interleukin Related CD3	Inflammation/Immunology Cancer
PI3Kδ-IN-25 is an orally active selective *PI3Kδ* inhibitor (IC₅₀ = 2.1 nM). PI3Kδ-IN-25 has IC₅₀s of 272, 285, and 1171 nM for PI3Kα, PI3Kγ, and PI3Kβ, respectively. PI3Kδ-IN-25 inhibits AKT Ser473 phosphorylation, suppresses Treg cell proliferation, and downregulates PD-L1 expression in B16F10 cells. PI3Kδ-IN-25 exhibits anticancer effects in B16F10 melanoma and Lewis lung cancer mouse models by reducing tumor-infiltrating Treg cells and enhancing immune responses. PI3Kδ-IN-25 is potentially useful in the study of melanoma, lung cancer, and other cancers .

HY-147898

PI3K-IN-33	PI3K Apoptosis	Cancer
PI3K-IN-33 (Compound 6e) is a highly selective *PI3K* inhibitor with IC₅₀ values of 11.73, 6.09 and 11.18 μM for PI3K-α、PI3K-β and PI3K-δ , respectively. PI3K-IN-33 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-33 can be used in leukemia research .

HY-147900

PI3K-IN-35	PI3K Apoptosis	Cancer
PI3K-IN-35 (Compound 6l) is a highly selective *PI3K* inhibitor with IC₅₀ values of 13.98, 7.22 and 10.94 μM for PI3K-α、PI3K-β and PI3K-δ, respectively. PI3K-IN-35 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-35 can be used in leukemia research .

Cat. No.	Product Name	Target	Research Area

HY-W040417

Boc-L-cyclobutylglycine	PI3K	Others
Boc-L-cyclobutylglycine is a Boc-protected L-cyclic amino acid and synthetic intermediate in the preparation of purinyl quinazolinone *PI3Kδ* inhibitors .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-18085

Quercetin 195+ Cited Publications	Flavonols Classification of Application Fields Anti-aging Endocrine diseases Plants Endogenous metabolite Human Gut Microbiota Metabolites Flavonoids Immune System Disorder Microorganisms other families Leguminosae Sunscreen Disease markers Cosmetic Research Glycyrrhiza uralensis Fisch. Disease Research Fields Source Classification Cancer	Reactive Oxygen Species (ROS) PI3K Autophagy Mitophagy Apoptosis
Quercetin, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a *PI3K* inhibitor with IC₅₀ of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-N0146

Quercetin dihydrate 190+ Cited Publications	Flavonols Flavonoids other families Classification of Application Fields Phenols Polyphenols Plants Disease Research Fields Source Classification Cancer	PI3K Apoptosis
Quercetin dihydrate, a natural flavonoid, is a stimulator of recombinant SIRT1 and a *PI3K* inhibitor with *IC₅₀s of 2.4 μM, 3.0 μM and 5.4 μM for PI3K* γ, PI3K δ and PI3K β, respectively .**

HY-18085R

Quercetin (Standard)	Flavonols Structural Classification Endocrine diseases Plants Endogenous metabolite Human Gut Microbiota Metabolites Flavonoids Immune System Disorder Microorganisms other families Leguminosae Disease markers Glycyrrhiza uralensis Fisch. Source Classification	Reactive Oxygen Species (ROS) Reference Standards PI3K Autophagy Mitophagy Apoptosis
Quercetin (Standard) is the analytical standard of Quercetin. This product is intended for research and analytical applications. Quercetin, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a PI3K inhibitor with IC50 of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-N0078

Ginkgolic Acid (C13:0) Ginkgolic acid (13:0); Ginkgoneolic Acid; 6-Tridecylsalicylic acid	Infection Monophenols Ginkgoaceae Classification of Application Fields Ketones, Aldehydes, Acids Phenols Plants Ginkgo biloba Disease Research Fields Source Classification	Bacterial PI3K Parasite
Ginkgolic Acid (C13:0) (Ginkgoneolic Acid) is an anti-cariogenic agent and a *PI3Kδ* inhibitor (IC₅₀: 2.49 μM). Ginkgolic Acid (C13:0) exhibits antibacterial and anti-parasitic activities. Ginkgolic Acid (C13:0) can also inhibit mast cell degranulation (IC₅₀: 2.40 μM) ^[3].

HY-N0146R

Quercetin dihydrate (Standard)	Flavonols Structural Classification Flavonoids other families Phenols Polyphenols Plants Source Classification	Reference Standards PI3K Apoptosis
Quercetin (dihydrate) (Standard) is the analytical standard of Quercetin (dihydrate). This product is intended for research and analytical applications. Quercetin dihydrate, a natural flavonoid, is a stimulator of recombinant SIRT1 and a PI3K inhibitor with IC₅₀s of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-N0078R

Ginkgolic Acid (C13:0) (Standard) Ginkgolic acid (13:0) (Standard); Ginkgoneolic Acid (Standard); 6-Tridecylsalicylic acid (Standard)	Structural Classification Monophenols Ginkgoaceae Ketones, Aldehydes, Acids Phenols Plants Ginkgo biloba Source Classification	Reference Standards Bacterial PI3K Parasite
Ginkgolic Acid (C13:0) (Standard) is the analytical standard of Ginkgolic Acid (C13:0) (HY-N0078). This product is intended for research and analytical applications. Ginkgolic Acid (C13:0) (Ginkgoneolic Acid) is an anti-cariogenic agent and a *PI3Kδ* inhibitor (IC₅₀: 2.49 μM). Ginkgolic Acid (C13:0) exhibits antibacterial and anti-parasitic activities. Ginkgolic Acid (C13:0) can also inhibit mast cell degranulation (IC₅₀: 2.40 μM) .

Cat. No.	Product Name	Chemical Structure

HY-18085S1

Quercetin-d3 1 Publications Verification
Quercetin-d₃ is the deuterium labeled Quercetin. Quercetin, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a PI3K inhibitor with IC₅₀ of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-18085S2

Quercetin-13C3
Quercetin- ¹³C₃ is the ¹³C-labeled Quercetin. Quercetin, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a PI3K inhibitor with IC₅₀ of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-17635S

Leniolisib-d5
Leniolisib-d5 is a deuterated labeled Leniolisib . Leniolisib (CDZ173) is a potent and selective *PI3Kδ* inhibitor. Leniolisib has the potential for immunodeficiency disorders treatment.

HY-18085S

Quercetin-d5
Quercetin-d₅ is a deuterium labeled Quercetin. Quercetin, a natural flavonoid, is a stimulator of recombinant SIRT1 and also a PI3K inhibitor with IC₅₀ of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

HY-18085AS

Quercetin-d3 hydrate 1 Publications Verification
Quercetin-d3 hydrate is a deuterium labeled Quercetin hydrate (HY-18085A), a flavonoid which can stimulate recombinant SIRT1 and also a *PI3K* inhibitor with IC₅₀s of 2.4 μM, 3.0 μM and 5.4 μM for PI3K γ, PI3K δ and PI3K β, respectively .

Host:	Rabbit (2)
Reactivity:	Human (2) Rat (2) Mouse (2)
Application:	ICC/IF (2) WB (2)
Isotype:	IgG (2)
Conjugation:	Non-conjugated (2)
Clonality:	Monoclonal (1) Recombinant (1)
Modification:	Unmodified (1)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81872

	PI3 Kinase p110 delta Antibody (YA1617) PIK3CD; Phosphatidylinositol 4; 5-bisphosphate 3-kinase catalytic subunit delta isoform; PI3-kinase subunit delta; PI3K-delta; PI3Kdelta; PtdIns-3-kinase subunit delta; Phosphatidylinositol 4; 5-bisphosphate 3-kinase 110 kDa catalytic subunit delta; PtdIns-3-kinase subunit p110-delta; p110delta	WB, ICC/IF	Human, Mouse, Rat
	PI3 Kinase p110 delta Antibody (YA1617) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PI3 Kinase p110 delta.

HY-P81872A

	PI3 Kinase p110 delta Antibody (YA1617)(PBS only) PIK3CD; Phosphatidylinositol 4; 5-bisphosphate 3-kinase catalytic subunit delta isoform; PI3-kinase subunit delta; PI3K-delta; PI3Kdelta; PtdIns-3-kinase subunit delta; Phosphatidylinositol 4; 5-bisphosphate 3-kinase 110 kDa catalytic subunit delta; PtdIns-3-kinase subunit p110-delta; p110delta	WB, ICC/IF	Human, Mouse, Rat
	PI3 Kinase p110 delta Antibody (YA1617) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PI3 Kinase p110 delta.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks